IMI 10th anniversary scientific symposium in October 2018
IMI was launched in 2008 as a public-private partnership (PPP) between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Since then, we have launched almost 100 projects, all of which take a collaborative, open innovation approach to some of the biggest challenges in medical research and drug development today, such as severe asthma, Alzheimer’s disease, diabetes and cancer, to name but a few. As IMI approaches its 10th anniversary, we have a chance to step back and reflect on 10 years of activity that has resulted in some amazing things happening thanks to the sterling work carried out in our projects.
Cancer, neurodegenerative disease and medicines safety feature in new IMI Call for proposalsmore
Four topics currently under consideration for inclusion in future IMI Calls for proposalsmore
SafeSciMET project trained more than 800 people in drug safety - an interview with project coordinatorsmore
IMI BROCHURE HIGHLIGHTS PROJECT SUCCESSES
IMI projects are accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. Furthermore, some of our projects are already delivering direct benefits to patients. Interested in concrete numbers and examples? Find out more about the impact and outputs of our projects in our new brochure, and learn how we are 'Carrying the torch for medical innovation'.
WATCH IMI video
Carrying the torch for medical innovation
Diseases keep changing, and infections we treated for decades can once again kill. By bringing together researchers from the public and private sectors, we are working to speed up medicines development and turn knowledge into treatments. Watch our #CarryTheTorch video and share it!